Benefits and Risks of Avastin Therapy
Avastin, in combination with carboplatin and paclitaxel, is approved to treat advanced nonsquamous nonsmall cell cancer (NSCLC) in people who have not yet received chemotherapy for their advanced cancer.
In studies, adding Avastin to carboplatin and paclitaxel (chemotherapy) has been shown to significantly increase overall survival among patients with NSCLC
Studies have also shown that adding Avastin to carboplatin and paclitaxel (chemotherapy) can help people with advanced NSCLC:
- Keep their cancer controlled longer
- Shrink their tumors
Studies have also shown that there are some serious side effects that may occur with Avastin therapy.
Side effects of Avastin in advanced NSCLC
See the table below for select side effects that increased by 2% or more in patients who added Avastin to carboplatin and paclitaxel (chemotherapy).
- *
- For treatment of advanced NSCLC, Avastin is used in combination with carboplatin and paclitaxel (chemotherapy).


